Sažetak
Background: The study aimed to explore the value of using non-invasive prenatal tests (NIPT) in the second trimester of pregnancy for chromosomal abnormality screening in vitro fertilization in elderly pregnant women and to analyze the reasons for inconsistent screening results in northwest China.
Methods: A total of 47,286 pregnant women aged 19-51 who underwent prenatal examinations were collected. NIPT detection found that the positive rate of pregnant women aged >35 with spontaneous pregnancy was 0.78%, and the positive rate of in vitro fertilization pregnancy was 0.82%. Then, the detection accuracy of NIPT for pregnant women aged >35 with in vitro fertilization was further analyzed.
Results: NIPT's sensitivity, specificity, and positive predictive value in detecting common chromosomal aneuploidies (T21, T18, and T13) in pregnant women aged >35 who received in vitro fertilization were 99.72%, 99.78%, and 66.45%, respectively. The mean gestational age, pregnancy number, AFP, and free β-HCG significantly differed between the positive and false positive groups (P < 0.05). Logistic analysis showed that the mean gestational age and AFP were independent risk factors for the failure of NIPT diagnosis (P < 0.05).
Conclusions: NIPT has a particular detection performance for common chromosomal aneuploidies in vitro fertilization in pregnant women. However, factors affecting detection accuracies must be considered when using it.
Ključne reči
Array
Array
Array
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.